Literature DB >> 16177080

Signal 3 tolerant CD8 T cells degranulate in response to antigen but lack granzyme B to mediate cytolysis.

Julie M Curtsinger1, Debra C Lins, Christopher M Johnson, Matthew F Mescher.   

Abstract

Naive CD8 T cells that respond in vivo to Ag and costimulation in the absence of a third signal, such as IL-12, fail to develop cytolytic function and become tolerized. We show in this study that CD8 T cells purified from TCR transgenic mice and stimulated in vitro in the presence or absence of IL-12 form conjugates with specific target cells, increase intracellular Ca2+, and undergo degranulation to comparable extents. Perforin is also expressed at comparable levels in the absence or presence of a third signal, but expression of granzyme B depends upon IL-12. Levels of granzyme B also correlate strongly with the cytolytic activity of cells responding in vivo. In contrast, an increase in CD107a (lysosomal-associated membrane protein 1) expression resulting from degranulation cannot distinguish in vivo generated lytic effector cells from tolerized, noncytolytic cells. Thus, it appears that cells rendered tolerant as a result of stimulation in the absence of a third signal fail to lyse target cells because they are "shooting blanks."

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177080     DOI: 10.4049/jimmunol.175.7.4392

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Interleukin-1R signaling is essential for induction of proapoptotic CD8 T cells, viral clearance, and pathology during lymphocytic choriomeningitis virus infection in mice.

Authors:  Lars T Joeckel; Reinhard Wallich; Sunil S Metkar; Christopher J Froelich; Markus M Simon; Christoph Borner
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

2.  Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host.

Authors:  Mark P Rubinstein; Colleen A Cloud; Tracy E Garrett; Caitlin J Moore; Kristina M Schwartz; C Bryce Johnson; David H Craig; Mohamed L Salem; Chrystal M Paulos; David J Cole
Journal:  J Am Coll Surg       Date:  2012-02-22       Impact factor: 6.113

3.  Direct activation of antigen-presenting cells is required for CD8+ T-cell priming and tumor vaccination.

Authors:  Wolfgang Kratky; Caetano Reis e Sousa; Annette Oxenius; Roman Spörri
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

4.  A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer.

Authors:  Gary K Koski; Ursula Koldovsky; Shuwen Xu; Rosemarie Mick; Anupama Sharma; Elizabeth Fitzpatrick; Susan Weinstein; Harvey Nisenbaum; Bruce L Levine; Kevin Fox; Paul Zhang; Brian J Czerniecki
Journal:  J Immunother       Date:  2012-01       Impact factor: 4.456

5.  Adipocytes as immune regulatory cells.

Authors:  Silvana A Vielma; Richard L Klein; Corinne A Levingston; M Rita I Young
Journal:  Int Immunopharmacol       Date:  2013-04-13       Impact factor: 4.932

6.  Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells.

Authors:  Tobias M Nowacki; Stefanie Kuerten; Wenji Zhang; Carey L Shive; Christian R Kreher; Bernhard O Boehm; Paul V Lehmann; Magdalena Tary-Lehmann
Journal:  Cell Immunol       Date:  2007-09-07       Impact factor: 4.868

7.  De novo recruitment of antigen-experienced and naive T cells contributes to the long-term maintenance of antiviral T cell populations in the persistently infected central nervous system.

Authors:  Jingxian Zhao; Jincun Zhao; Stanley Perlman
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

8.  Simian immunodeficiency virus (SIV)-specific CD8+ T-cell responses in vervet African green monkeys chronically infected with SIVagm.

Authors:  Roland C Zahn; Melisa D Rett; Birgit Korioth-Schmitz; Yue Sun; Adam P Buzby; Simoy Goldstein; Charles R Brown; Russell A Byrum; Gordon J Freeman; Norman L Letvin; Vanessa M Hirsch; Jörn E Schmitz
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

9.  The level of friend retrovirus replication determines the cytolytic pathway of CD8+ T-cell-mediated pathogen control.

Authors:  Gennadiy Zelinskyy; Sandra Balkow; Simone Schimmer; Tanja Werner; Markus M Simon; Ulf Dittmer
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

10.  Allogeneic differences in the dependence on CD4+ T-cell help for virus-specific CD8+ T-cell differentiation.

Authors:  Christopher C Kemball; Eva Szomolanyi-Tsuda; Aron E Lukacher
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.